Arena Pharmaceuticals, Inc. Message Board
-
Buy a few shares under four cents today.
Company is sponsoring N.F.L. Brain Injury Conference in Minneapolis next week.
Google the recent Seeking Alpha article by bio-tech analyst Jason Napadano.
"Amarantus Teams With Becton, Dickinson For LymPro Development, Seeking PD-LID Candidate" -
Stocks go up and they go down.
-
The company's patented MANF technology could be worth billions in the treatment of a number of neurological diseases such as Alzheimer's and Parkinson's.
The company is sponsoring the N.F.L. Head Injury Symposium being held in Minneapolis later this month.
Due diligence.
p.s. Buy a few shares under a dime. -
Recoup some losses.
-
With almost 8,000,000 shares "short" and the daily trading volume dropping any positive news will move this above $1.00.
-
This is one news event away from rebounding above $1.00.
-
Substantially undervalued. Currently trading under $1.00 on the AMEX. Check it out.
Over $2,000,000,000 in known reserves. -
Substantially undervalued.
-
This sucks.
-
Let's keep it above .63.
-
Same as usual.
- Reply to
35% of Gross Sales Versus 35% of Net Sales - "The Lemonade Stand"
by scanit2008 •Jun 7, 2013 3:53 AMInteresting analogy.
-
With a decision still nine months away.
Would Al sell the company for $20.00/share? -
The difference between net and gross could be a factor of three to four times.
-
Nice swings today.
-
$600,000,000?
Isn't Arena's market cap speculatively high? -
Read the transcript from the most recent quarterly report. Due to the locations of the mines I think the company will be forced to operate at a loss for some time. Political considerations are important.
Average down when it hits the .52-.55 range. Bottom at .46.
I don't see it going lower than that even with a market correction.
Interesting months ahead for GSS and the market. -
Add a few shares here.
-
As long as it closes above .65 we're in good shape here.
If it goes lower add a few shares. -
Still oversold.